RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

Prime Capital Investment Advisors, LLC's Holding History (CIK: 0001731446)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 27,902 Value ($000) $114 Avg Close $4.95 Range $3.81 - $7.18

Q3 2025

Shares 27,403 Value ($000) $134 Avg Close $5.25 Range $4.45 - $7.15

Q2 2025

Shares 30,346 Value ($000) $154 Avg Close $4.91 Range $3.79 - $6.11

Q1 2025

Shares 18,854 Value ($000) $100 Avg Close $7.29 Range $5.19 - $12.36

Q4 2024

Shares 11,473 Value ($000) $78 Avg Close $6.72 Range $5.60 - $9.55

Q3 2024

Shares 10,167 Value ($000) $67 Avg Close $7.17 Range $5.88 - $8.73

Q2 2024

Shares 10,178 Value ($000) $76 Avg Close $8.72 Range $6.75 - $10.66

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	27,902	$114	$4.95	$3.81 - $7.18
Q3 2025	27,403	$134	$5.25	$4.45 - $7.15
Q2 2025	30,346	$154	$4.91	$3.79 - $6.11
Q1 2025	18,854	$100	$7.29	$5.19 - $12.36
Q4 2024	11,473	$78	$6.72	$5.60 - $9.55
Q3 2024	10,167	$67	$7.17	$5.88 - $8.73
Q2 2024	10,178	$76	$8.72	$6.75 - $10.66